organophosphonates has been researched along with Cell Transformation, Viral in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, JM; Carroll, PA; DeFilippis, VR; Früh, K; Lagunoff, M; Moses, AV; Roberts, CT; Rose, PP | 1 |
| Agranat, I; Bentor, Y; Gelfand, T; Goldblum, N; Manor, D; Margalith, M | 1 |
| Gangemi, JD; Johnson, JA | 1 |
| Balzarini, J; De Clercq, E; Naesens, L | 2 |
5 other study(ies) available for organophosphonates and Cell Transformation, Viral
| Article | Year |
|---|---|
The insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcoma.
Topics: Cell Line, Transformed; Cell Transformation, Viral; Endothelial Cells; Herpesvirus 8, Human; Humans; Mitogen-Activated Protein Kinases; Naphthalenes; Organophosphonates; Receptor, IGF Type 1; Receptor, Insulin; RNA, Small Interfering; Sarcoma, Kaposi | 2007 |
Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.
Topics: Animals; Antigens, Viral; Callitrichinae; Cell Division; Cell Line; Cell Survival; Cell Transformation, Viral; DNA Replication; Fetal Blood; Herpesvirus 4, Human; Kinetics; Lymphocytes; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid; Propionates; Virus Replication | 1980 |
Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
Topics: Antiviral Agents; Cell Cycle; Cell Transformation, Viral; Cells, Cultured; Cidofovir; Cytosine; Humans; Keratinocytes; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Tumor Virus Infections | 1999 |
Single-dose administration of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the prophylaxis of retrovirus infection in vivo.
Topics: Adenine; Animals; Animals, Newborn; Antiviral Agents; Cell Line; Cell Transformation, Viral; Drug Administration Schedule; Injections, Intraperitoneal; Mice; Moloney murine sarcoma virus; Organophosphonates; Sarcoma, Experimental | 1991 |
Anti-retrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in vivo increases when it is less frequently administered.
Topics: Adenine; Animals; Antiviral Agents; Cell Transformation, Viral; Cytopathogenic Effect, Viral; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HIV-1; Mice; Mice, Inbred C3H; Moloney murine sarcoma virus; Neoplasm Transplantation; Organophosphonates; Retroviridae; Sarcoma, Experimental; Time Factors; Zidovudine | 1990 |